Market Tracker

06/27 7:07am ET

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

5.64
Delayed Data
As of Jun 24
 0.00 / 0.00%
Today’s Change
4.56
Today|||52-Week Range
14.93
-32.13%
Year-to-Date
ZIOPHARM Oncology (ZIOP) Is Today's Dead Cat Bounce Stock
Jun 20 / TheStreet.com - Paid Partner Content
4 Cancer Drug Developers You Need to Have on Your Radar This Year
Jun 15 / MotleyFool.com - Paid Partner Content
Better Buy: Ziopharm Oncology, Inc. vs. Celgene
Jun 18 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close5.64
Today’s openn.a.
Day’s range5.61 - 6.02
Volume423,777
Average volume (3 months)2,565,546
Market cap$780.5M
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)-209.68%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+215.51%
P/E ratioNM
Price/Sales240.58
Price/Book8.92

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S0.000.00%
RGENRepligen Corp0.000.00%
MACKMerrimack Pharmaceut...0.000.00%
SRPTSarepta Therapeutics...0.000.00%
Data as of 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.3M
Annual profit (last year)-$120.1M
Net profit margin-2,772.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Managing Director
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts